Copenhagen, Denmark, 6 November 2022 - FluoGuide A/S is pleased to announce that FG001 lights up in 5 out of 7 patients in an interim evaluation in the ongoing phase IIa trial in non-small cell lung. | November 6, 2022
Despite having less smokers, lung cancer cases will increase over the coming decade. Dr Niamh Logan and Dr Parthiban Nadarajan – Department of Respiratory